Published in Ann Intern Med on August 01, 1967
In vitro reactivity of human lymphocytes in uraemia--a comparison with the impairment of delayed hypersensitivity. Clin Exp Immunol (1969) 1.73
Immunological studies in Kaposi's sarcoma in Uganda. Br Med J (1970) 1.47
Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol (1975) 1.40
Significance of the changes in the circulating lymphoid cells in Hodgkin's disease. Br Med J (1969) 1.35
Leukocyte antimicrobial function in patients with leprosy. J Clin Invest (1974) 1.31
Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells. Clin Exp Immunol (1971) 1.31
Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis. Infect Immun (1979) 1.19
Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest (1980) 1.19
Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes. Clin Exp Immunol (1975) 1.17
Quantitative dinitrochlorobenzene contact sensitization in a normal population. Clin Exp Immunol (1972) 1.15
Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes. J Clin Invest (1973) 1.11
Immunological studies in tropical splenomegaly syndrome in Uganda. Br Med J (1969) 1.11
Immunologic studies in patients with malignant melanoma in Uganda. Br J Cancer (1969) 0.96
Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases. Clin Exp Immunol (1975) 0.94
Lymphocyte transformation during dinitrochlorobenzene contact sensitization. An in vitro and in vivo evaluation of the primary immune response in man. J Clin Invest (1973) 0.94
Cell-mediated immune responses in patients with paracoccidioidomycosis. Clin Exp Immunol (1977) 0.93
T and B lymphocytes in patients with lepromatous leprosy. Clin Exp Immunol (1974) 0.91
Immunological aspects of clinical leprosy. Proc R Soc Med (1970) 0.90
Immunological studies in children with acute viral hepatitis. Clin Exp Immunol (1975) 0.88
Quantitation of immunocompetence in Hodgkin's disease. J Clin Invest (1975) 0.88
Contribution of modern immunological concepts to an understanding of diseases of the skin. Br Med J (1970) 0.83
Inhibition of granuloma formation around Schistosoma mansoni eggs. V. "Hodgkin's-like lesion" in SJ J mice. Am J Pathol (1969) 0.81
Immune responsiveness in Hodgkin's disease. Br J Cancer Suppl (1973) 0.81
Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. Br J Cancer (1982) 0.78
The role of immunology in human cancer research. Can Med Assoc J (1970) 0.77
Concanavalin A receptors on the surface membrane of lymphocytes from patient's with Hodgkin's disease and other malignant lymphomas. Proc Natl Acad Sci U S A (1975) 0.75
Immunity in tumours of the skin. Studies on cell-mediated immune reactions. Arch Dermatol Forsch (1975) 0.75
Post-mortem findings in Ugandans with Hodgkin's disease. Br J Cancer (1972) 0.75
The effect of quadruple chemotherapy on the peripheral blood lymphocyte populations in Hodgkin's disease. Br J Clin Pharmacol (1977) 0.75
Immunological aspects of Hodgkin's disease. Proc R Soc Med (1972) 0.75
Diseases associated with immunosuppression. Environ Health Perspect (1982) 0.75
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Structure of yeast phenylalanine tRNA at 3 A resolution. Nature (1974) 10.27
New rapid gel sequencing method for RNA. Nature (1977) 9.56
Structure of nucleosome core particles of chromatin. Nature (1977) 6.24
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03
The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett (1985) 4.73
Structure of yeast phenylalanine transfer RNA at 2.5 A resolution. Proc Natl Acad Sci U S A (1975) 4.57
The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragments. EMBO J (1993) 4.11
Outcomes of stroke patients in Medicare fee for service and managed care. JAMA (1997) 3.91
A crystallographic study of metal-binding to yeast phenylalanine transfer RNA. J Mol Biol (1977) 3.71
Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
Estimating hospital costs. A multiple-output analysis. J Health Econ (1986) 3.09
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Current methods of transfer of young people with Type 1 diabetes to adult services. Diabet Med (2002) 2.76
Further refinement of the structure of yeast tRNAPhe. J Mol Biol (1978) 2.71
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Degradation of collagen by a human granulocyte collagenolytic system. J Clin Invest (1968) 2.62
The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61
Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) (2001) 2.41
Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30
Nodular lymphoma--evidence for origin from follicular B lymphocytes. N Engl J Med (1974) 2.26
Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA. Biochemistry (1985) 2.22
Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13
Alfentanil for conscious sedation during colonoscopy. South Med J (1995) 2.07
Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04
Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol (1989) 1.99
A model for the tertiary structure of the 28 residue DNA-binding motif ('zinc finger') common to many eukaryotic transcriptional regulatory proteins. Protein Eng (1988) 1.98
Atomic co-ordinates for yeast phenylalanine tRNA. Nucleic Acids Res (1975) 1.98
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
Pb(II)-catalysed cleavage of the sugar-phosphate backbone of yeast tRNAPhe--implications for lead toxicity and self-splicing RNA. Nature (1983) 1.92
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88
Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med (1973) 1.83
Time-limited certification and recertification: the program of the American Board of Internal Medicine. The Task Force on Recertification. Ann Intern Med (1991) 1.83
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
X-ray diffraction study of a new crystal form of the nucleosome core showing higher resolution. J Mol Biol (1981) 1.81
Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79
Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med (1966) 1.73
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant (2007) 1.70
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med (1997) 1.70
Human granulocyte collagenase. Science (1968) 1.68
Differing roles for zinc fingers in DNA recognition: structure of a six-finger transcription factor IIIA complex. Proc Natl Acad Sci U S A (1998) 1.67
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med (1995) 1.67
The home health visit: an appropriate unit for Medicare payment? Health Aff (Millwood) (1996) 1.67
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med (1975) 1.65
Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J Sci Am (2006) 1.64
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab (2014) 1.63
Fatal Clostridium difficile enteritis after total abdominal colectomy. J Clin Gastroenterol (1996) 1.63
Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma. Ann Intern Med (1967) 1.62
Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res (1966) 1.62
Kallmann syndrome: MR findings. AJNR Am J Neuroradiol (1993) 1.60
Fingers and helices. Nature (1987) 1.59
Correlation between three-dimensional structure and chemical reactivity of transfer RNA. Nucleic Acids Res (1974) 1.58
Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med (1966) 1.58
Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) (1991) 1.56
Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med (2000) 1.51
Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50
Lessons from zinc-binding peptides. Annu Rev Biophys Biomol Struct (1997) 1.49
Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med (1972) 1.49
More on the contraindications to vasoconstrictors in dentistry. Oral Surg Oral Med Oral Pathol (1993) 1.46
Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med (1972) 1.44
Impairment of intestinal deconjugation of dietary folate. A possible explanation of megaloblastic anaemia associated with phenytoin therapy. Lancet (1968) 1.42
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42
Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant (2009) 1.42
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41
Workers' compensation introduction for physicians. Va Med Q (1995) 1.40
The future of dentistry. Dent Today (2001) 1.40
Acute intermittent porphyria. New morphologic and biochemical findings. Am J Med (1966) 1.38
Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone. J Pediatr (1993) 1.38
Malignant lymphomas: current classification and new observations. Pathol Annu (1975) 1.38
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Purification and crystallization of the EcoRV restriction endonuclease. J Biol Chem (1985) 1.37
Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA (1966) 1.34
Cancer treatment and age: patient perspectives. J Natl Cancer Inst (1993) 1.34
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer (1976) 1.33
Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. J Natl Cancer Inst (1972) 1.32
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer (1982) 1.32
Use of extreme position changes in acute respiratory failure. Crit Care Med (1976) 1.31
House staff attitudes toward teaching. J Med Educ (1970) 1.30
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29
Functional markers: a new perspective on malignant lymphomas. Cancer Treat Rep (1977) 1.29
L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29
In vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst (1971) 1.27
Cardiovascular function in shock. Responses to volume loading and isoproterenol infusion. Circulation (1967) 1.26
Why do so few HMOs offer Medicare risk plans in rural areas? Health Care Financ Rev (1995) 1.26
Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol (1986) 1.26
Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26